1. Home
  2. GXAI vs SNGX Comparison

GXAI vs SNGX Comparison

Compare GXAI & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GXAI
  • SNGX
  • Stock Information
  • Founded
  • GXAI 2021
  • SNGX 1987
  • Country
  • GXAI United States
  • SNGX United States
  • Employees
  • GXAI N/A
  • SNGX N/A
  • Industry
  • GXAI
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • GXAI
  • SNGX Health Care
  • Exchange
  • GXAI Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • GXAI 7.5M
  • SNGX 7.4M
  • IPO Year
  • GXAI 2023
  • SNGX 1987
  • Fundamental
  • Price
  • GXAI $1.71
  • SNGX $2.41
  • Analyst Decision
  • GXAI
  • SNGX
  • Analyst Count
  • GXAI 0
  • SNGX 0
  • Target Price
  • GXAI N/A
  • SNGX N/A
  • AVG Volume (30 Days)
  • GXAI 505.4K
  • SNGX 49.5K
  • Earning Date
  • GXAI 03-26-2025
  • SNGX 03-14-2025
  • Dividend Yield
  • GXAI N/A
  • SNGX N/A
  • EPS Growth
  • GXAI N/A
  • SNGX N/A
  • EPS
  • GXAI N/A
  • SNGX N/A
  • Revenue
  • GXAI $2,979.00
  • SNGX $364,183.00
  • Revenue This Year
  • GXAI N/A
  • SNGX N/A
  • Revenue Next Year
  • GXAI N/A
  • SNGX $76.64
  • P/E Ratio
  • GXAI N/A
  • SNGX N/A
  • Revenue Growth
  • GXAI N/A
  • SNGX N/A
  • 52 Week Low
  • GXAI $1.01
  • SNGX $1.83
  • 52 Week High
  • GXAI $19.20
  • SNGX $14.88
  • Technical
  • Relative Strength Index (RSI)
  • GXAI 43.93
  • SNGX 46.88
  • Support Level
  • GXAI $1.41
  • SNGX $2.25
  • Resistance Level
  • GXAI $1.63
  • SNGX $2.60
  • Average True Range (ATR)
  • GXAI 0.13
  • SNGX 0.15
  • MACD
  • GXAI 0.02
  • SNGX 0.04
  • Stochastic Oscillator
  • GXAI 64.08
  • SNGX 68.18

About GXAI Gaxos.ai Inc.

Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: